Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- More Questions Than Answers: Dealing With Rheumatic Complications of Immunomodulators
-
- Immunomodulators Azathioprine/6-Mercaptopurine and Methotrexate David T. Rubin, MD; Miles P. Sparrow, MBBS, FRACP
- Top Osteoarthritis Stories Posted in January
- FDA Grants Priority Review for Actemra to Treat Giant Cell Arteritis
- Tofacitinib Provides 'Reduction' in Inflammation for Patients With Ankylosing Spondylitis
- There is No Such Thing as a Free Lunch
- The Management of Comorbid Conditions in Patients With Rheumatoid Arthritis
- Expert Offers Insight on Reducing Infection Risk With RA Therapies
- FDA Guidance Recommends Distinct Names, Suffixes for Biosimilars
-
- FDA Issues Draft Guidance on Biosimilar Interchangeability
- Hip Shape May Predict Likelihood of Surgery 10 Years Later
- Jaw MRI Appears to Reliably Assess Synovitis in Patients With JIA
- New Program Linked With Increased Rate of Shingles Vaccination for Patients With RA
- Smoking Cessation Lessened Effect of Spondyloarthritis
- Study Cites Factors for Mortality Among Patients With Recent Onset of Gout
- TNF Inhibitors Linked to Lower Risk for Heart Attack vs sDMARDs
- Triple Therapy Seen as More Cost-effective Than Etanercept Therapies
-
- Frailty Associated With Mortality in Patients With Lupus
- Filgotinib Improved Patient-reported Outcomes, Shows Potential
- Study: Nearly One-third of Adults With Pre-diabetes Also Have Arthritis
- Survey: Physicians Would Like More Goal-oriented Communication With Patients